Cohort protocol: Guangzhou High-Risk Infant Cohort study

Pian Hu1, Azhu Han1, Yan Hu1

  • 1Department of Child Health Care, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

BMJ Open
|October 17, 2020
PubMed

Insights

The Guangzhou High-Risk Infant Cohort (GHRIC) investigates factors affecting high-risk infants (HRIs) in China. This study aims to improve neurodevelopmental outcomes for these vulnerable newborns.

Area of Science:

  • Pediatrics
  • Neurodevelopmental Disorders
  • Public Health

Background:

  • High-risk infants (HRIs) show increasing survival rates globally.
  • However, motor and neurodevelopmental sequelae prevalence remains high in HRIs.
  • Limited research exists on HRIs in China, highlighting a knowledge gap.

Purpose of the Study:

  • To establish the Guangzhou High-Risk Infant Cohort (GHRIC) in China.
  • To examine factors influencing the growth and neurodevelopment of HRIs.
  • To identify risk factors and prognoses for improved infant development.

Main Methods:

  • Prospective cohort study enrolling 3000 HRIs by 2023.
  • Data collection includes risk factors, neurodevelopmental/cognitive evaluations, lab results, and specimens.
  • Follow-up until age 6 to record interventions and outcomes.

Main Results:

  • Data collection and analysis are ongoing.
  • The study aims to identify key developmental trajectories and influencing factors.
  • Results will inform targeted interventions for HRIs.

Conclusions:

  • The GHRIC study is crucial for understanding HRI development in China.
  • Findings will contribute to improved neurodevelopmental outcomes for high-risk infants.
  • This research will inform clinical practice and public health strategies.
Abstract